Last reviewed · How we verify

NCT03108872

Left Atrial Appendage Occlusion Versus New Oral Anticoagulants for Stroke Prevention in Patients With Non-valvular Atrial Fibrillation

Status unknown Last updated 24 May 2017
What this trial tests

trial testing left atrial appendage occlusion in Atrial Fibrillation in 300 participants. Status unknown.

Timeline
23 May 2017
Primary endpoint
30 September 2017
30 October 2017

Quick facts

Lead sponsorSejong General Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment300
Start date23 May 2017
Primary completion30 September 2017
Estimated completion30 October 2017
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Sejong General Hospital

Who can join

Adults 30 to 85, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We will compare long-term effectiveness and safety in patients with atrial fibrillation treated with left atrial appendage occlusion versus new oral anticoagulants to prevent ischemic stroke from multicenter registry data

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

Other Sejong General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03108872.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing